Baseline mannose binding lectin levels may not predict infection among children with leukemia

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 866-868

  Rubnitz, Jeffrey E ^a,b   Howard, Scott C ^a,b   Willis, Jennifer ^a   Pui, Ching Hon ^a,b   Pounds, Stanley ^a,b   Hayden, Randall T ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Infection; Leukemia; Mannose binding lectin

Indexed keywords

MANNOSE BINDING LECTIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; CHILDHOOD LEUKEMIA; FEBRILE NEUTROPENIA; HUMAN; INCIDENCE; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MYCOSIS; PREDICTION; PRIORITY JOURNAL;

CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEVER; HUMANS; INFECTION; LEUKEMIA; MANNOSE-BINDING LECTIN; NEUTROPENIA; PREDICTIVE VALUE OF TESTS;

EID: 40449121881     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21320     Document Type: Article

References (20)

1. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998;199:327-339.
2. Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991;337:1569-1570.
3. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992;1:709-715.
4. Sastry K, Herman GA, Day L, et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989;170:1175-1189.
5. Taylor ME, Brickell PM, Craig RK, et al. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989;262:763-771.
6. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-3020.
7. Madsen HO, Satz ML, Hogh B, et al. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998;161:3169-3175.
8. Roy S, Knox K, Segal S, et al. MBL genotype and risk of invasive pneumococcal disease: A case-control study. Lancet 2002;359: 1569-1573.
9. Summerfield JA, Sumiya M, Levin M, et al. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997;314:1229-1232.
10. Summerfield JA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-889.
11. Neth O, Hann I, Turner MW, et al. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:614-618.
12. Peterslund NA, Koch C, Jensenius JC, et al. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001;358:637-638.
13. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002;99:3524-3529.
14. Bergmann OJ, Christiansen M, Laursen I, et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003;70:91-97.
15. Frakking FN, van dW, Brouwer N, et al. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 2006;42:909-916.
16. Crews KR, Gandhi V, Srivastava DK, et al. Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. J Clin Oncol 2002;20:4217-4224.
17. Kishi S, Griener J, Cheng C, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003;21:3084-3091.
18. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;1:80-83.
19. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980. pp. 163-188.
20. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Statist. 1988;16:1141-1154.